Follow this preprint
Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?
Benjamin Davido, Thibaud Lansaman, Simon Bessis, Christine Lawrence, Jean-Claude Alvarez, Hélène Mascitti, Frédérique Bouchand, Pierre Moine, Véronique Perronne, Aurélie Le Gal, Djillali Annane, Christian Perronne, Pierre De Truchis on behalf of the COVID-19 RPC Team
doi: https://doi.org/10.1101/2020.05.05.20088757
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Benjamin Davido
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Thibaud Lansaman
2Rééducation fonctionnelle, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Simon Bessis
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Christine Lawrence
3EOH, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Jean-Claude Alvarez
4Pharmaco-toxicologie, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Hélène Mascitti
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Frédérique Bouchand
5Pharmacie Hospitalière, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Pierre Moine
6Réanimation médicale, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Véronique Perronne
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Aurélie Le Gal
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Djillali Annane
6Réanimation médicale, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Christian Perronne
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France
Pierre De Truchis
1Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches, France

Data Availability
All data are available for the journal editor on request.
Posted May 11, 2020.
Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?
Benjamin Davido, Thibaud Lansaman, Simon Bessis, Christine Lawrence, Jean-Claude Alvarez, Hélène Mascitti, Frédérique Bouchand, Pierre Moine, Véronique Perronne, Aurélie Le Gal, Djillali Annane, Christian Perronne, Pierre De Truchis
medRxiv 2020.05.05.20088757; doi: https://doi.org/10.1101/2020.05.05.20088757
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
6
Comment
0
TRIP Peer Reviews
1
Community Reviews
0
Automated Services
32
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3180)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13156)
- Forensic Medicine (18)
- Gastroenterology (879)
- Genetic and Genomic Medicine (4988)
- Geriatric Medicine (458)
- Health Economics (764)
- Health Informatics (3143)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4736)
- Nursing (252)
- Nutrition (701)
- Oncology (2437)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (88)
- Pathology (524)
- Pediatrics (1265)
- Primary Care Research (539)
- Public and Global Health (7302)
- Radiology and Imaging (1641)
- Respiratory Medicine (954)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)